Will NYS Miss the Biotech Train?

CGR's Gleason Center for State Policy explored NYS's financial return from investments in biotech R&D. CGR found that investments in biotech are likely to yield a greater economic impact than investments in physical science research.

Report Date: Jun 2001
Author(s): Kent Gardner
Subject(s): Economic Analysis
Location: New York State

You Might Also Like

• Economic Impact of URMC Strategic Plan: Phase II Expans Initial Impact Project
• Health & Bioscience as Engine of Economic Growth: Case Studies of Academic Medical Centers & Their Economic Impact
• Solutions for New York The Economic Significance of Independent Colleges and Universities in New York State